Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


23.04.2018

1 AJR Am J Roentgenol
2 Ann Oncol
1 Ann Thorac Surg
4 BMC Cancer
1 Br J Cancer
1 Cancer Cell
1 Cancer Chemother Pharmacol
2 Cancer Lett
1 Cancer Res
1 Cancer Sci
2 Clin Lung Cancer
1 Clin Nucl Med
1 Int J Cancer
2 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Nucl Med
1 J Thorac Cardiovasc Surg
9 Lung Cancer
3 N Engl J Med
1 Oncogene
1 Oncol Rep
1 Oncologist
2 Proc Natl Acad Sci U S A
2 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. KISHIDA Y, Seki S, Yoshikawa T, Itoh T, et al
    Performance Comparison Between (18)F-FDG PET/CT Plus Brain MRI and Conventional Staging Plus Brain MRI in Staging of Small Cell Lung Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 18:1-8. doi: 10.2214/AJR.17.18935.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. WANG H, Agulnik J, Kasymjanova G, Wang A, et al
    Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.
    Ann Oncol. 2018 Apr 12. pii: 4969231. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. NOVELLO S, Mazieres J, Oh IJ, de Castro J, et al
    Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study.
    Ann Oncol. 2018 Apr 14. pii: 4970555. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  4. CHAN EKL, Andrade LEC
    Clarification Needed Regarding Anti-Topoisomerase I as a Biomarker for Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Apr 18. pii: S0003-4975(18)30530.
    PubMed     Text format    


    BMC Cancer

  5. ABBAS HHK, Alhamoudi KMH, Evans MD, Jones GDD, et al
    MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
    BMC Cancer. 2018;18:423.
    PubMed     Text format     Abstract available

  6. DHONT L, Pintilie M, Kaufman E, Navab R, et al
    Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).
    BMC Cancer. 2018;18:429.
    PubMed     Text format     Abstract available

  7. HE F, Xiao RD, Lin T, Xiong WM, et al
    Dietary patterns, BCMO1 polymorphisms, and primary lung cancer risk in a Han Chinese population: a case-control study in Southeast China.
    BMC Cancer. 2018;18:445.
    PubMed     Text format     Abstract available

  8. MISHRA DK, Miller RA, Pence KA, Kim MP, et al
    Small cell and non small cell lung cancer form metastasis on cellular 4D lung model.
    BMC Cancer. 2018;18:441.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. DOHERTY JA, Grieshober L, Houck JR, Barnett MJ, et al
    Nested case-control study of telomere length and lung cancer risk among heavy smokers in the beta-Carotene and Retinol Efficacy Trial.
    Br J Cancer. 2018 Apr 19. pii: 10.1038/s41416-018-0075.
    PubMed     Text format     Abstract available


    Cancer Cell

  10. HELLMANN MD, Nathanson T, Rizvi H, Creelan BC, et al
    Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 12. pii: S1535-6108(18)30123.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  11. FUJITA K, Uchida N, Kanai O, Okamura M, et al
    Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases.
    Cancer Chemother Pharmacol. 2018 Apr 19. pii: 10.1007/s00280-018-3585.
    PubMed     Text format     Abstract available


    Cancer Lett

  12. YU X, Zhang Y, Ma X, Pertsemlidis A, et al
    miR-195 Potentiates the Efficacy of Microtubule-Targeting Agents in Non-Small Cell Lung Cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30268.
    PubMed     Text format     Abstract available

  13. JING P, Zhao N, Ye M, Zhang Y, et al
    Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Cancer Lett. 2018 Apr 18. pii: S0304-3835(18)30286.
    PubMed     Text format     Abstract available


    Cancer Res

  14. SU W, Feng S, Chen X, Yang X, et al
    Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer.
    Cancer Res. 2018 Apr 18. pii: 0008-5472.CAN-18-0222.
    PubMed     Text format     Abstract available


    Cancer Sci

  15. WANG Y, Lei L, Zheng YW, Zhang L, et al
    Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and beta-catenin.
    Cancer Sci. 2018 Apr 16. doi: 10.1111/cas.13614.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  16. SIO TT, Prayongrat A, Zhang Y, Lin Q, et al
    The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30048.
    PubMed     Text format     Abstract available

  17. PAXIMADIS P, Beebe-Dimmer JL, George J, Schwartz AG, et al
    Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30059.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  18. ZHAO Z, Zhou K, Liu B
    Added Value of SPECT/CT in the Evaluation of Sacral Fracture in Patients With Lung Cancer.
    Clin Nucl Med. 2018 Apr 13. doi: 10.1097/RLU.0000000000002082.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. LA FLEUR L, Boura VF, Alexeyenko A, Berglund A, et al
    Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31545.
    PubMed     Text format     Abstract available


    Int J Oncol

  20. DIAZ-RODRIGUEZ E, Sanz E, Pandiella A
    Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4373.
    PubMed     Text format     Abstract available

  21. ZHANG Y, Li XJ, He RQ, Wang X, et al
    Upregulation of HOXA1 promotes tumorigenesis and development of nonsmall cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Apr 16. doi: 10.3892/ijo.2018.4372.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  22. SCHAPIRA E, Hubbeling H, Yeap BY, Mehan WA Jr., et al
    Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2018 Mar 22. pii: S0360-3016(18)30542.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  23. ROJKO L, Reiniger L, Teglasi V, Fabian K, et al
    Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients.
    J Cancer Res Clin Oncol. 2018 Apr 19. pii: 10.1007/s00432-018-2642.
    PubMed     Text format     Abstract available


    J Nucl Med

  24. MCHUGH C, Thipparthi MR, Lawhorn-Crews JM, Polin L, et al
    Utilizing radiolabeled 3'-deoxy-3'-[(18)F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
    J Nucl Med. 2018 Apr 19. pii: jnumed.117.207258. doi: 10.2967/jnumed.117.207258.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  25. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed     Text format    


    Lung Cancer

  26. KANG YK, Song YS, Cho S, Jheon S, et al
    Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
    Lung Cancer. 2018;119:1-6.
    PubMed     Text format     Abstract available

  27. MODING EJ, Diehn M, Wakelee HA
    Circulating tumor DNA testing in advanced non-small cell lung cancer.
    Lung Cancer. 2018;119:42-47.
    PubMed     Text format     Abstract available

  28. D'SILVA A, Gardiner PA, Boyle T, Bebb DG, et al
    Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: A quantile regression approach.
    Lung Cancer. 2018;119:78-84.
    PubMed     Text format     Abstract available

  29. RAEZ LE, Cardona AF, Santos ES, Catoe H, et al
    The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments.
    Lung Cancer. 2018;119:7-13.
    PubMed     Text format     Abstract available

  30. YANG SM, Chen LW, Wang HJ, Chen LR, et al
    Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
    Lung Cancer. 2018;119:56-63.
    PubMed     Text format     Abstract available

  31. FUJIMOTO D, Yoshioka H, Kataoka Y, Morimoto T, et al
    Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.
    Lung Cancer. 2018;119:14-20.
    PubMed     Text format     Abstract available

  32. BORGHAEI H, Yim YM, Guerin A, Pivneva I, et al
    Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy.
    Lung Cancer. 2018;119:112-119.
    PubMed     Text format     Abstract available

  33. BURUDPAKDEE C, Wong W, Seetasith A, Corvino FA, et al
    Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer.
    Lung Cancer. 2018;119:103-111.
    PubMed     Text format     Abstract available

  34. CHRISTOPOULOS P, Schneider MA, Bozorgmehr F, Kuon J, et al
    Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
    Lung Cancer. 2018;119:48-55.
    PubMed     Text format     Abstract available


    N Engl J Med

  35. GANDHI L, Rodriguez-Abreu D, Gadgeel S, Esteban E, et al
    Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
    N Engl J Med. 2018 Apr 16. doi: 10.1056/NEJMoa1801005.
    PubMed     Text format     Abstract available

  36. FORDE PM, Chaft JE, Smith KN, Anagnostou V, et al
    Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
    N Engl J Med. 2018 Apr 16. doi: 10.1056/NEJMoa1716078.
    PubMed     Text format     Abstract available

  37. HELLMANN MD, Ciuleanu TE, Pluzanski A, Lee JS, et al
    Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
    N Engl J Med. 2018 Apr 16. doi: 10.1056/NEJMoa1801946.
    PubMed     Text format     Abstract available


    Oncogene

  38. TOMOSHIGE K, Guo M, Tsuchiya T, Fukazawa T, et al
    An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0240.
    PubMed     Text format     Abstract available


    Oncol Rep

  39. LIU L, Han C, Yu H, Zhu W, et al
    Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrialmediated apoptosis.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6363.
    PubMed     Text format     Abstract available


    Oncologist

  40. CHABNER BA, Nabel CS
    Canakinumab and Lung Cancer: Intriguing, but Is It Real?
    Oncologist. 2018 Apr 17. pii: theoncologist.2018-0116.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  41. TUNG B, Schade B, Cardiff RD, Aina OH, et al
    beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201610383.
    PubMed     Text format     Abstract available

  42. CHEN P, Zuo H, Xiong H, Kolar MJ, et al
    Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201614035.
    PubMed     Text format     Abstract available


    Thorax

  43. ATHEY VL, Walters SJ, Rogers TK
    Symptoms at lung cancer diagnosis are associated with major differences in prognosis.
    Thorax. 2018 Apr 17. pii: thoraxjnl-2018-211596.
    PubMed     Text format     Abstract available

  44. WALTER JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, et al
    Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Thorax. 2018 Apr 16. pii: thoraxjnl-2017-211376.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: